Literature DB >> 1417511

Neurologic signs in Alzheimer's disease. Results of a prospective clinical and neuropathologic study.

H Förstl1, A Burns, R Levy, N Cairns, P Luthert, P Lantos.   

Abstract

Neurologic signs and their neuropathologic correlates were examined in a sample of 56 patients with autopsy-proved Alzheimer's disease (13 men, 43 women; mean age at death, 83.1 years; range, 67 to 96 years) from a prospective longitudinal study. Full-range regular rigidity with cog-wheeling was found in 20 patients and was significantly associated with lower neuron counts in the substantia nigra and with the presence of Lewy bodies in the brain stem and neocortex. Twelve patients with myoclonus had a younger age at onset, a lower age at death (mean, 78.6 years), and lower neuron counts in the serotoninergic dorsal raphe nucleus and in the noradrenergic locus coeruleus than did the patients without myoclonus. Generalized motor seizures were reported in six patients, and they had significantly lower counts of pyramidal cells in cortical layers III through IV of the parietal cortex (area 7) and slightly decreased pyramidal cell numbers in the parahippocampal gyrus (area 28). The 19 patients with a positive grasp reflex had an earlier onset of illness and a significantly inferior performance on the Mini-Mental State examination and Cambridge Cognitive Examination tests. They, and 25 patients with a positive snout reflex, had significantly lower counts of large pyramidal cells in layers III through V of the frontal cortex (area 32). These results indicate that different neurologic symptoms in Alzheimer's disease can be related to disproportionate neuronal degeneration in functionally different brain areas.

Entities:  

Mesh:

Year:  1992        PMID: 1417511     DOI: 10.1001/archneur.1992.00530340054018

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  18 in total

Review 1.  Seizures and epilepsy in Alzheimer's disease.

Authors:  Daniel Friedman; Lawrence S Honig; Nikolaos Scarmeas
Journal:  CNS Neurosci Ther       Date:  2011-06-07       Impact factor: 5.243

2.  Seizures and epileptiform activity in the early stages of Alzheimer disease.

Authors:  Keith A Vossel; Alexander J Beagle; Gil D Rabinovici; Huidy Shu; Suzee E Lee; Georges Naasan; Manu Hegde; Susannah B Cornes; Maya L Henry; Alexandra B Nelson; William W Seeley; Michael D Geschwind; Maria L Gorno-Tempini; Tina Shih; Heidi E Kirsch; Paul A Garcia; Bruce L Miller; Lennart Mucke
Journal:  JAMA Neurol       Date:  2013-09-01       Impact factor: 18.302

Review 3.  [Alzheimer's disease and epilepsy].

Authors:  R Haussmann; T Mayer; W Schrempf; M Donix
Journal:  Nervenarzt       Date:  2017-09       Impact factor: 1.214

4.  Pathophysiological considerations of seizures, epilepsy, and status epilepticus in the elderly.

Authors:  Rebecca M Verellen; Jose E Cavazos
Journal:  Aging Dis       Date:  2011-08-30       Impact factor: 6.745

Review 5.  Diagnostic confirmation, severity, and subtypes of Alzheimer's disease. A short review on clinico-pathological correlations.

Authors:  H Förstl; P Fischer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

6.  Incidence and impact of subclinical epileptiform activity in Alzheimer's disease.

Authors:  Keith A Vossel; Kamalini G Ranasinghe; Alexander J Beagle; Danielle Mizuiri; Susanne M Honma; Anne F Dowling; Sonja M Darwish; Victoria Van Berlo; Deborah E Barnes; Mary Mantle; Anna M Karydas; Giovanni Coppola; Erik D Roberson; Bruce L Miller; Paul A Garcia; Heidi E Kirsch; Lennart Mucke; Srikantan S Nagarajan
Journal:  Ann Neurol       Date:  2016-11-07       Impact factor: 10.422

Review 7.  Seizures in elderly patients with dementia: epidemiology and management.

Authors:  Mario Mendez; Gerald Lim
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

8.  Seizures in Alzheimer disease: clinical and epidemiological data.

Authors:  Dionysios Pandis; Nikolaos Scarmeas
Journal:  Epilepsy Curr       Date:  2012-09       Impact factor: 7.500

Review 9.  Neurologic and motor dysfunctions in APP transgenic mice.

Authors:  Robert Lalonde; Ken-Ichiro Fukuchi; Catherine Strazielle
Journal:  Rev Neurosci       Date:  2012       Impact factor: 4.353

10.  Decreased phospholipase A2 activity in the brain and in platelets of patients with Alzheimer's disease.

Authors:  W F Gattaz; N J Cairns; R Levy; H Förstl; D F Braus; A Maras
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.